Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis

Clinical and Experimental Allergy

Volumn 34, Issue 2, 2004, Pages 259-267

  Di Lorenzo, G ^a,c   Pacor, M L ^b   Pellitteri, M E ^a   Morici, G ^a   Di Gregoli, A ^a   Lo Bianco, C ^a   Ditta, V ^a   Martinelli, N ^b   Candore, G ^a   Mansueto, P ^a   Rini, G B ^a   Corrocher, R ^b   Caruso, C ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Dipartimento di Medicina Clinica e delle Patologie Emergenti   (Italy)

Author keywords

Cetirizine; Eosinophil cationic protein; Eosinophils; Fluticasone propionate; Montelukast; Nasal lavage; Parietaria; Pollen season

Indexed keywords

CETIRIZINE; FLUTICASONE; MONTELUKAST;

ALLERGIC RHINITIS; AQUEOUS SOLUTION; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EOSINOPHIL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; NASAL PRURITUS; NOSE CONGESTION; NOSE MUCUS; PARIETARIA; POLLEN; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SNEEZING;

ACETATES; ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANDROSTADIENES; BLOOD PROTEINS; CETIRIZINE; CHILD; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EOSINOPHIL GRANULE PROTEINS; FEMALE; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; QUINOLINES; RHINITIS, ALLERGIC, SEASONAL; RIBONUCLEASES;

EID: 12144291569     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.01877.x     Document Type: Article

References (35)

1. Bousquet J, van Cauwenberge P, Khaltaev N et al. Allergic rhinitis and its impact on asthma. Workshop report in collaboration with the World Health Organisation 2001. J Allergy Clin Immunol 2001; 108 (Suppl. 5):S147-334.
2. van Cauwenberge P, Bachert C, Passalacqua G et al. Consensus statement on the treatment of allergic rhinitis. Allergy 2000; 55:116-34.
3. 1 receptor antagonists in allergic rhinitis, systematic review of randomised controlled trials. Br Med J 1998; 317:1624-9.
4. Smith LJ. Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma. Biodrugs 2001; 15:239-49.
5. Sorkness CA. Leukotriene receptor antagonists in the treatment of asthma. Pharmacotherapy 2001; 21:S34-7.
6. Ducharme FM, Hicks GC. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma. Cochrane Database Syst Rev 2000; 3:CD002314.
7. Meltzer EO, Malmstrom K, Lu S et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 2000; 105:917-22.
8. Wilson AM, Orr LC, Sims EJ, Lipworth BJ. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 2001; 31:61-8.
9. Wilson AM, Sims EJ, Orr LC et al. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2001; 87:344-9.
10. Di Lorenzo G, Mansueto P, Melluso M et al. Non specific airway hyperresponsiveness in mono-sensitive Sicilian patients with allergic rhinitis. Its relation to total serum IgE levels and blood eosinophils during and out of the pollen season. Clin Exp Allergy 1997; 27:1052-9.
11. Dacie JV, Lewis SM. Eosinophil counts by counting chamber method. In: Lewis SM, Bain BJ, Bates I, eds. Practical Haematology. Edinburgh: Churchill Livingstone, 1984: 42-3.
12. Di Lorenzo G, Gervasi F, Drago A et al. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics. Clin Exp Allergy 1999; 29:1367-77.
13. Di Lorenzo G, Drago A, Esposito Pelliteri M et al. Measurement of inflammatory mediators of mast cell and eosinophils in native nasal fluid lavage in nasal polyposis. Int Arch Allergy Immunol 2001; 25:164-75.
14. Erdfelder E, Faul F, Buchner A. GPower: a general power analysis program. Behav Res Meth, Instr Comput 1996; 28:1-11.
15. Howarth PH. The cellular basis for allergic rhinitis. Allergy 1995; 50:6-10.
16. Di Lorenzo G, Mansueto P, Melluso M et al. Allergic rhinitis to Grass pollen: measurement of inflammatory mediators of mast cell and eosinophils in native nasal fluid lavage and in serum out and during pollen season. J Allergy Clin Immunol 1997; 100:832-7.
17. Mygind N, Dahl R. The rationale use of topical corticosteroids in allergic rhinitis. Clin Exp Allergy 1996; 26 (Suppl. 3):2-10.
18. Dujukanovic R, Wilson SJ, Howarth H. Pathology of rhinitis and bronchial asthma. Clin Exp Allergy 1996; 26 (Suppl. 3):44-51.
19. Palczynsky C, Krakowiak A, Ruta U et al. Nasal response to allergen challenge in patients with immediate asthmatic reaction. Allergol Immunopathol (Madr) 1996; 24:237-42.
20. Ortolani C, Foresi Athe FLNC02 Italian Study Group et al. A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. Allergy 1999; 54:1173-80.
21. Pullerits T, Praks L, Skoogh BE, Ani R, Lotvall J. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Am J Respir Crit Care Med 1999; 159:1814-8.
22. Pullerits T, Praks L, Ristioja V, Ltvall J. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2002; 109:949-55.
23. Godthelp T, Holm AF, Klein-Jan A, Rijntjes E, Fokkens WJ. The effect of fluticasone propionate aqueous nasal spray on nasal mucosal inflammatory in perennial allergic rhinitis. Allergy 1995; 50:21-4.
24. D'Ambrosio FP, Gangemi S, Merendino RA, Arena A, Ricciardi L, Bagnato GF. Comparative study between fluticasone propionate and cetirizine in the treatment of allergic rhinitis. Allergol Immunopathol (Madr) 1998; 26:277-82.
25. Jordana G, Dolovich J, Briscoe MP et al. Intranasal fluticasone propionate vs. loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97:588-95.
26. Darnell R, Pecoud A, Richards DH. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen. Clin Exp Allergy 1994; 24:1144-50.
27. Barnes PJ. Molecular mechanisms of corticosteroids in allergic diseases. Allergy 2001; 56:928-36.
28. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998; 157:S1-53.
29. Di Lorenzo G, Pacor ML, Esposito-Pellitteri M et al. In vitro effects of fluticasone propionate on interleukin-13 production by mitogen-stimulated. Mediat Inflamm 2002; 11:187-90.
30. Diamant Z, Grootendorst DC, Veselic-Charvat M et al. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy 1999; 29:42-51.
31. Miadonna A, Tedeschi A, Leggieri E et al. Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis. Am Rev Respir Dis 1987; 136:357-62.
32. 4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans. Clin Allergy 1986; 60:289-97.
33. 4 in allergic rhinitis. Ann Allergy 1988; 60:537-40.
34. Grossman J, Ratner PH, Nathan R, Adelglass J, de Jong B. Pranlukast (Ultair™, SB 205312, ONO-1078), an oral leukotriene receptor antagonist, relieves symptoms in patients with seasonal allergic rhinitis (SAR) (abstract). J Allergy Clin Immunol 1997; 99:S443.
35. Nielsen LP, Mygind N, Dahl R. Intranasal corticosteroids for allergic rhinitis: superior relief? Drugs 2001; 61:1563-79.